CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression

Απλή σελίδα τεκμηρίου
dc.contributor.authorIoannidis, P.en
dc.contributor.authorMahaira, L.en
dc.contributor.authorPapadopoulou, A.en
dc.contributor.authorTeixeira, M. R.en
dc.contributor.authorHeim, S.en
dc.contributor.authorAndersen, J. A.en
dc.contributor.authorEvangelou, E.en
dc.contributor.authorDafni, U.en
dc.contributor.authorPandis, N.en
dc.contributor.authorTrangas, T.en
dc.date.accessioned2015-11-24T19:26:25Z
dc.date.available2015-11-24T19:26:25Z
dc.identifier.issn0250-7005-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22722
dc.rightsDefault Licence-
dc.subjectAnimalsen
dc.subjectAntigens, Neoplasm/biosynthesis/genetics/*physiologyen
dc.subjectGene Expression Regulation, Developmentalen
dc.subjectHumansen
dc.subjectNeoplasms/genetics/metabolismen
dc.subjectProto-Oncogene Proteins c-myc/biosynthesis/*geneticsen
dc.subjectRNA, Messenger/genetics/*metabolismen
dc.subjectRNA-Binding Proteins/biosynthesis/genetics/*physiologyen
dc.titleCRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expressionen
heal.abstractThe Coding Region Determinant-Binding Protein (CRD-BP) is an RRM and KH-domain-containing protein that recognizes specifically at least three RNAs. It binds to one of the two c-myc mRNA instability elements, to the 5'Un Translated Region (UTR) of the leader 3 IGF-II mRNA and to the oncofetal H19 RNA. CRD-BP has been assigned a role in stabilizing c-myc mRNA by preventing its endonucleolytic cleavage and in repressing the translation of the leader 3 IGF-II mRNA, the major embryonic species of this message. CRD-BP is normally expressed only in fetal tissues. However, its expression is detected in primary tumors and transformed cell lines of different origins. The vast majority of colon (80%) and breast (60%) tumors and sarcomas (73%) express CRD-BP whereas in other tumor types, for example prostate carcinomas, its expression is rare. CRD-BP expression has also been detected in benign tumors such as breast fibroadenomas, meningiomas and other benign mesenchymal tumors, implying a role for this gene in abnormal cell proliferation. In breast carcinomas, CRD-BP expression and or gene copy number gains in the region encompassing the c-myc locus were detected in approximately 75% of tumors, implying that the deregulated expression of c-myc may be more widespread than previously believed. Infiltrated lymph nodes, corresponding to CRD-BP-positive primary tumors, were also found positive indicating that monitoring for CRD-BP could prove useful for the detection and monitoring of disseminated disease.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/12894594-
heal.journalNameAnticancer Researchen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2003-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ